Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Status unconfirmed · Phase 1

Conditions studied: Solid Malignancies, Non-Hodgkin's Lymphoma

In brief

The purposes of this study are to determine: * the largest dose of AQ4N that can be safely given once a week for three weeks out of a 4 week cycle * the side effects of AQ4N when given on the above schedule * how much AQ4N is in the blood and urine at specific times after administration and how the body get rids of AQ4N * if AQ4N helps treat cancer

Key facts

Study ID
NCT00090727
Run by
Novacea
People needed
45
Starts
2004-08-01
Last updated by the study team
2006-11-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.